Literature DB >> 30553628

A case of pulmonary mucormycosis presented as Pancoast syndrome and bone destruction in an immunocompetent adult mimicking lung carcinoma.

J Yang1, J Zhang2, Y Feng3, F Peng4, F Fu5.   

Abstract

Pulmonary mucormycosis is a rare opportunistic infection caused by Mucormycosis. This fungal infection is uncommon in immunocompetent individuals. Because of its various clinical and imaging manifestations, it is a diagnostic challenge to distinguish pulmonary mucormycosis from other pulmonary diseases, such as carcinoma. Herein, we report a case of pulmonary mucormycosis presenting as Pancoast syndrome and bone destruction of ribs. A 46-year-old Chinese woman was admitted due to pain in chest, right neck and arm for four months and hoarseness for one week. The pre-admission diagnosis via chest CT was pulmonary carcinoma. The subsequent bronchoalveolar lavage fluid analysis and bronchoscopic biopsy were negative for malignant cells, except chronic inflammation. Imaging-guided percutaneous biopsies were carried out after admission and the final pathological diagnosis was pulmonary mucormycosis. Although the patient was started on oral posaconazole of 400mg bid, the disease condition continued to deteriorate. She finally died of respiratory failure.
Copyright © 2018 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Computed tomography; Immunocompetent; Pancoast syndrome; Pulmonary mucormycosis

Mesh:

Substances:

Year:  2018        PMID: 30553628     DOI: 10.1016/j.mycmed.2018.10.005

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  4 in total

1.  Isolated cerebral mucormycosis masquerading as a tumor in an immunocompetent patient.

Authors:  Smita Chandra; Shubhi Sharma; Ruchir Vats; Sanjeev Pandey
Journal:  Autops Case Rep       Date:  2021-01-28

2.  Pulmonary mucormycosis mimicking lung tumour in an uncontrolled diabetic patient.

Authors:  Elham Sadat Banimostafavi; Mahdi Fakhar; Zakaria Zakariaei; Ali Sharifpour; Mostafa Soleymani
Journal:  Respirol Case Rep       Date:  2022-02-23

Review 3.  Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients.

Authors:  P Monika; M N Chandraprabha
Journal:  Mol Biol Rep       Date:  2022-02-02       Impact factor: 2.742

4.  Rhizopus microsporus lung infection in an immunocompetent patient successfully treated with amphotericin B: A case report.

Authors:  Long Chen; Yuan Su; Xian-Zhi Xiong
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.